The Global Fund to Fight Aids, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002–2014)
Bibliographic Data
| ID | 14908706 |
|---|---|
| Authors | Jamie Bridge (corresponding author), Benjamin M Hunter (0000-0002-5848-5245, King's College London), E Albers (0000-0001-6668-1011), Catherine M Cook (0000-0003-3976-6858), Catherine Cook, Mauro Guarinieri (Global Fund to Fight AIDS, Tuberculosis and Malaria), Jeffrey V Lazarus (0000-0001-9618-2299, Rigshospitalet), Jack MacAllister (American Foundation for AIDS Research), Susie McLean (International HIV/AIDS Alliance), Daniel Wolfe (0000-0002-8392-9506, Open Society Foundations) |
| Year | 2016 |
| Volume | 27 |
| Pages | 132-137 |
| Publication date | 2016-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2015.08.001 |
| PMID | 26342275 |
| OpenAlex | W1186891767 |
| Language | EN |
| Citations received | 8 |
| References cited | 5 |
This study represents an updated, comprehensive assessment of Global Fund investments in harm reduction from its founding (2002) until the start of the new funding model (2014). It also highlights the overall shortfall of harm reduction funding, with the estimated global need being US$ 2.3 billion for harm reduction in 2015 alone. Using this baseline, the Global Fund must carefully monitor its new funding model and ensure that investments in harm reduction are maintained or scaled-up. There are widespread concerns regarding the withdrawal from middle-income countries where harm reduction remains essential and unfunded through other sources: for example, 15% of the identified investments were for countries which are now ineligible for Global Fund support
Business · Harm · Harm reduction · Human immunodeficiency virus (HIV · Malaria · Political science · Reduction (mathematics · Tuberculosis · Hepatitis B Virus Studies · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Law · Medicine · Immunology · Virology
Public health and international drug policy
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs
The role of the Technical Review Panel of the Global Fund to Fight HIV/Aids, Tuberculosis and Malaria
The Uncounted
The Global Fund’s paradigm of oversight, monitoring, and results in Mozambique
Sexual Risk Behaviors of Patients with HIV/Aids over the Course of Antiretroviral Treatment in Northern Vietnam
The Role of Context in Integrating Buprenorphine into a Drop-In Center in Kampala, Uganda, Using the Consolidated Framework for Implementation Research
What does sustainability mean in the HIV and Aids response
| Unique citing works | 8 |
|---|---|
| Citations per year | 0,8 |
| Citation span | 2016 - 2022 (7) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 8 |